Heart Failure - Chronic References

Last updated: 27 October 2025
  1. MedWormhttp://www.medworm.com/rss/index.php/Cardiology/7/http://www.medworm.com/rss/medicalfeeds/specialities/Cardiology.xml
  2. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  3. MedWorm - Heart Failurehttp://www.medworm.com/rss/medicalfeeds/conditions/Heart-Failure-News.xml
  4. Yancy CW, Jessup M, Bozkurt B, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016 Sep 27;68(13):1476-1488. doi: 10.1016/j.jacc.2016.05.011. Accessed 10 Jun 2016. PMID: 27216111
  5. Ponikowski P, Voors AA, Anker SD, et al; Authors/Task Force Members; Document reviewers. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016 May 20:1-85. doi: 10.1002/ejhf.592. Accessed 08 Jun 2016. PMID: 27207191
  6. Abarquez RF Jr, Reganit PF, Chungunco CN, et al. Chronic heart failure clinical practice guidelines' class 1-A pharmacologic recommendations: start-to-end synergistic drug therapy. ASEAN Heart J. 2016 Mar 8;24(1):4. doi: 10.7603/s40602-016-0004-5. Accessed 15 Jul 2016. PMID: 27054142
  7. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017 Aug;136(6):e137-e161. doi: 10.1161/CIR.0000000000000509. Accessed 09 Aug 2017. PMID: 28455343
  8. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. Accessed 16 Nov 2017. PMID: 29146535
  9. NHFA CSANZ Heart Failure Working Group; Atherton JJ, Sindone A, Pasquale CG, et al. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018. Heart Lung Circ. 2018 Oct;27(10):1123-1208. doi: 10.1016/j.hlc.2018.06.1042. Accessed 21 Mar 2019. PMID: 30077227
  10. National Institute for Health and Care Excellence (NICE). Chronic heart failure in adults: diagnosis and management. NICE. https://www.nice.org.uk/. Sep 2018. Accessed 21 Mar 2019.
  11. Academy of Medicine Malaysia, Ministry of Health Malaysia, National Heart Association of Malaysia. Clinical practice guidelines management of heart failure 2019. 4th ed. National Heart Association of Malaysia. https://www.malaysianheart.org. 04 Sep 2019. Accessed 10 Sep 2019.
  12. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the Diagnosis and Management of Chronic Coronary Syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425. Accessed 10 Sep 2019. PMID: 31504439
  13. Seferovic PM, Ponikowski P, Anker SD, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019 Oct;21(10):1169-1186. doi: 10.1002/ejhf.1531. Accessed 02 Oct 2019. PMID: 31129923
  14. van der Meer P, Gaggin HK, Dec GW. ACC/AHA versus ESC guidelines on heart failure: JACC guideline comparison. J Am Coll Cardiol. 2019 Jun 04;73(21):2756-2768. doi: 10.1016/j.jacc.2019.03.478. Accessed 02 Oct 2019. PMID: 31146820
  15. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391. Accessed 17 Sep 2020. PMID: 28886619
  16. Writing Committee; Maddox TM, Januzzi Jr JL, Allen LA, et al. 2021 Update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021 Jan 04;S0735-1097(20)37867-0. doi: 10.1016/j.jacc.2020.11.022. PMID: 33446410
  17. Kuin BKW, Yee OH, Ping CLS, et al. 2020 Clinical practice guidelines on the diagnosis and management of heart failure - a comprehensive updated guideline from the Heart Failure Society (Singapore). Heart Failure Society (Singapore). https://www.hfss.org.sg. 2020. Accessed 27 Jan 2021.
  18. European Society for Cardiology (ESC). ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. ESC. https://www.escardio.org. 10 Jun 2020. Accessed 22 Feb 2021.
  19. Tsutsui H, Isobe J, Ito H, et al. JCS 2017/JHFS 2017 Guideline on diagnosis and treatment of acute and chronic heart failure - digest version. Circ J. 2019 Sep 25;83(10):2084-2184. doi: 10.1253/circj.CJ-19-0342. PMID: 31511439
  20. Bozkurt B, Hershberger RE, Butler J, et al. 2021 ACC/AHA key data elements and definitions for heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure). J Am Coll Cardiol. 2021 Apr 27;77(16):2053-2150. doi: 10.1016/j.jacc.2020.11.012. PMID: 33250265
  21. National Health Service (NHS). Alcohol units. NHS. https://www.nhs.uk. 13 Apr 2018. Accessed 05 Jul 2021.
  22. McDonagh TA, Metra M, Adamo M, et al; ESC Scientific Document Group. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368. Accessed 15 Dec 2021. PMID: 34447992
  23. Visseren FLJ, Mach F, Smulders YM, et al; ESC National Cardiac Societies, ESC Scientific Document Group. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484. Accessed 15 Dec 2021. PMID: 34458905
  24. American Diabetes Association. Standards of medical care in diabetes - 2020. Diabetes Care. 2020 Jan;43(Suppl 1):S1-S212. https://care.diabetesjournals.org. Accessed 06 Jan 2020
  25. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. PMID: 35363499
  26. The Task Force for the Management of COVID-19 of the European Society of Cardiology (ESC). ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J. 2022 Mar 14;43(11):1059-1103. doi: 10.1093/eurheartj/ehab697. Accessed 28 May 2022. PMID: 34791154
  27. Ariyachaipanich A, Buakhamsri A, Phrommintikul A, et al. 2022 HFCT focused update of the 2019 HFCT heart failure guidelines: part 1 – heart failure classification and pharmacological treatment for heart failure with reduced ejection fraction (HFrEF). J Med Assoc Thai. 2022;105(11):1153-1159. doi: 10.35755/medassocthai.2022.11.13702. Accessed 12 Mar 2023
  28. Borlaug BA. Pathophysiology of heart failure with preserved ejection fraction. UpToDate. https://www.uptodate.com. 22 Oct 2021.
  29. Bozkurt B, Coats AJS, Tsutsui H, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. Eur J Heart Fail. 2021 Mar;23(3):352-380. doi: 10.1002/ejhf.2115. Accessed 12 Mar 2023. PMID: 33605000
  30. Colucci WS, Borlaug BA. Heart failure: clinical manifestations and diagnosis in adults. UpToDate. https://www.uptodate.com. 20 Apr 2022.
  31. Colucci WS. Pathophysiology of heart failure with reduced ejection fraction: hemodynamic alterations and remodeling. UpToDate. https://www.uptodate.com. 11 Aug 2022.
  32. National Institute for Care and Excellence (NICE). Chronic heart failure in adults. NICE. https://www.nice.org.uk/. 10 Jan 2023. Accessed 14 Jan 2023.
  33. Schwinger RHG. Pathophysiology of heart failure. Cardiovasc Diagn Ther. 2021 Feb;11(1):263-276. doi: 10.2017/cdt-20-302. PMID: 33708498
  34. Vasan RS, Wilson PWF. Epidemiology of heart failure. UpToDate. https://www.uptodate.com. 23 Nov 2022.
  35. AstraZeneca. Farxiga extended in the US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients. AstraZeneca. https://www.astrazeneca.com. 09 May 2023.
  36. Kittleson MM, Panjrath GS, Amancherla K, et al. 2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 May 9;81(18):1835-1878. doi: 10.1016/j.jacc.2023.03.393. PMID: 37137593
  37. Inpefa highlights of prescribing information. GlobeNewswire. https://www.lexpharma.com. May 2023.
  38. Lexicon Pharmaceuticals. Lexicon announces FDA approval of Inpefa (sotagliflozin) for treatment of heart failure. GlobeNewswire. https://www.globenewswire.com. 26 May 2023.
  39. Marx N, Federici M, Schutt K, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023 Aug 25;ehad192. doi: 10.1093/eurheartj/ehad192. Accessed 04 Sep 2023. PMID: 37622663
  40. McDonagh TA, Metra M, Adamo M, et al. 2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023 Aug 25;ehad195. doi: 10.1093/eurheartj/ehad195. PMID: 37622666
  41. Heart Failure Clinical Practice Guideline Task Force 2023. Philippine clinical practice guidelines on the diagnosis and management of chronic heart failure with reduced ejection fraction for primary care physicians. Department of Health Philippines. https://doh.gov.ph. 2023.
  42. Writing Committee; Maddox TM, Januzzi Jr JL, Allen LA, et al. 2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024 Mar 2;S0735-1097(23):08354-7. doi: 10.1016/j.jacc.2023.12.024. PMID: 38466244
  43. Mullens W, Damman K, Dhont S, et al. Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. Eur J Heart Fail. 2024 Apr;26(4):730-741. doi: 10.1002/ejhf.3244. PMID: 38606657
  44. Writing Committee; Hollenberg SM, Stevenson LW, Ahmad T, et al. 2024 ACC expert consensus decision pathway on clinical assessment, management, and trajectory of patients hospitalized with heart failure focused update: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024 Sep 24;84(13):1241-1267. doi: 10.1016/j.jacc.2024.06.002. PMID: 39127954
  45. Ministry of Health Malaysia, Academy of Medicine Malaysia and National Heart Association of Malaysia. Clinical practice guidelines. Management of heart failure 2023. 5th Edition. Academy of Medicine of Malaysia. https://www.acadmed.org. 2023.